Melbourne researchers believe that understanding how kangaroos repair their DNA could be the key to preventing skin cancer in the future.
02/12/2009
RESEARCHERS at TGen Clinical Research Service (TCRS) at Scottsdale Healthcare have analysed clinical trial results of potential new investigational therapy for advanced and metastatic basal cell skin cancer.
09/09/2009
A PATIENT who was prescribed a course of anti-cancer drugs has lost his finger prints, causing him to be detained in the United States.
29/05/2009
AUSTRALIAN research published this week in The American Chemical Society’s Journal of Medicinal Chemistry describes a new radiopharmaceutical tracer which promises to give clearer pictures of melanoma and could lead to improved disease treatment.
08/10/2009
A NEW DRUG designed to “seek and destroy” common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare.
06/10/2009
RESEARCHERS claim to have developed a mouse model that allows them to replicate normal pigment cells at the earliest stages of their conversion into malignant skin cancer in humans.
17/03/2009
ACCORDING to a report by Nehmat Houssami in the Annals of Oncology, women who survived a primary breast cancer were more likely to survive a subsequent case if detected early.
20/03/2009
RESEARCHERS from the National Cancer Institute’s Centre for Cancer Research have identified a gene called PTEN which may play an important role in the formation of melanoma.
27/03/2009
Recent developments in RNAi, particularly in the design of lentiviral-based short hairpin RNA (shRNA), now allow researchers to potentially develop diagnostic and prognostic strategies for treating cancer and metastasis.
03/11/2009
University of Sydney researchers have been awarded a Federal Government grant for their work in ready-made skin replacements for third and second degree burns.
11/02/2010
THE SCLERODERMA Foundation says scleroderma is an autoimmune disease which leads to thickening and severe scarring of skin as well as thickening and failure of internal organs affecting approximately 300,000 Americans.
13/03/2009
University of Melbourne medical researchers, Professors Frank Carbone and Mark Smyth, have received AUD$4 million NHMRC Australia Fellowships for their work in chronic infectious diseases and cancer research respectively.
11/02/2010
NOVABAY Pharmaceuticals has announced preclinical animal data showing that NVC-422, the company's lead Aganocide compound, was effective in treating subcutaneous dermatophyte (skin fungus) infections.
16/03/2009
PEPLIN has announced the initiation of two Phase III clinical trials to confirm the efficacy and safety of PEP005 (ingenol mebutate) Gel for the treatment of actinic (solar) keratoses (AK), a common pre-cancerous skin lesion, when applied to head locations includuing the face and scalp
10/06/2009
DIONEX has announced the use of an efficient method for the determination of the eight main, active components of giant knotweed rhizome, a common Chinese medicinal plant.
27/07/2009
THE MATHWORKS has announced theCleveland FES Center in the United States, using tools for Model-Based Design, has developed research technology which more quickly restores movement to individuals with neuromuscular disabilities.
08/10/2009
BAYER Schering Pharma has announced the results of Phase I and II trials of BAY 73-4506 an oral multi-kinase inhibitor currently being studied in multiple tumour types.
03/06/2009
PEPLIN says it has completed the enrolment of its two Phase 3 clinical trials for the use of PEP005 ingenol mebutate gel to treat actinic keratoses.
07/07/2009
BAYER Schering Pharma has announced results from a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase inhibitor.
07/10/2009
BRISBANE dermatology company Peplin has announced a definitive merger agreement whereby LEO Pharma (LEO) will acquire all outstanding securities of Peplin for approximately US$287.5 million (currently A$348.4 million) in cash.
07/09/2009